Providers

Latest News

One of the most promising findings from the study was the identification of potential biomarkers in alopecia areata. | Image Credit: onephoto - stock.adobe.com
Ritlecitinib Spurs Hair Regrowth in Alopecia Areata

September 5th 2025

The findings add confidence to the role of ritlecitinib as a treatment option for severe alopecia areata while pointing the way toward more personalized approaches.

While immunogenicity is often reduced, vaccination remains indispensable in multiple myeloma, according to the review. | Image credit: alernon77 - stock.adobe.com
Vaccination Remains Essential in Multiple Myeloma Despite Impaired Responses

September 4th 2025

The new guideline emphasizes the role of lifestyle behaviors in high blood pressure, recommending that providers help patients set realistic goals. | Image credit: naowarat - stock.adobe.com
Prevention, Early Intervention Highlighted in Updated High Blood Pressure Guidelines

September 4th 2025

While atopic dermatitis was found to be the most burdensome disease and received the most grants, the correlation between disease burden and NIH funding deteriorated as the investigators went down the list of burdensome diseases. | Image credit: GRON777 - stock.adobe.com
NIH Pediatric Dermatology Spending Misaligned With Disease Burden

September 4th 2025

Most of the patients who experienced superior outcomes with atezolizumab and chemotherapy had higher levels of NOTCH1 expression. | Image credit: Pixel-Shot - stock.adobe.com
NOTCH1 Levels Impact Immune Response in SCLC

September 2nd 2025

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo